A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: Implications for cellular magnetic resonance imaging

NMR in Biomedicine

Volumn 18, Issue 6, 2005, Pages 383-389

  Arbab, Ali S ^a,b   Wilson, Lindsey B ^a   Ashari, Parwana ^a   Jordan, Elaine K ^a   Lewis, Bobbi K ^a   Frank, Joseph A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Endosome lysosome; Ferumoxides; Labeled cells; Poly L lysine; SPIO

Indexed keywords

ELECTRON MICROSCOPY; IRON OXIDES; MAGNETIC RESONANCE IMAGING; METABOLISM; NANOSTRUCTURED MATERIALS; NUCLEAR MAGNETIC RESONANCE; PH; SODIUM COMPOUNDS;

ENDOSOME; FERUMOXIDES; LABELED CELLS; LYSOSOME; POLY-L-LYSINE; SODIUM CITRATE; SUPERPARAMAGNETIC IRON OXIDE (SPIO) NANOPARTICLES;

CELLS;

BUFFER; CHELATING AGENT; CITRATE SODIUM; DEXTRAN; FERRIC ION; IRON; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CELL CULTURE; CELL LABELING; CELL TRANSPORT; CELLULAR DISTRIBUTION; DEGRADATION; DISSOCIATION; ELECTRON MICROSCOPY; ENDOCYTOSIS; ENDOSOME; IN VIVO STUDY; INCUBATION TIME; LYSOSOME; MESENCHYMAL STEM CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; PRIORITY JOURNAL; RELAXATION TIME; TRANSPORT KINETICS;

CELL SEPARATION; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; CONTRAST MEDIA; DEXTRANS; HUMANS; IRON; LYSOSOMES; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELLS; METABOLIC CLEARANCE RATE; NANOTUBES; OXIDES; STAINING AND LABELING;

EID: 26244447885     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.970     Document Type: Article

References (33)

1. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR Am. J. Roentgenol. 1990; 155: 943-950.
2. Pouliquen D, Le Jeune JJ, Perdrisot R, Ermias A, Jallet P. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn. Reson. Imag. 1991; 9: 275-283.
3. Weissleder R, Stark DD, Engelstad BL, Becon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am. J. Roentgenol. 1989; 152: 167-173.
4. Schulze E, Ferrucci JT, Poss K, lapointe L, Bogdanova A, Weissleder R. Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Invest. Radiol. 1995; 30: 604-610.
5. Link G, Pinson A, Hershko C. Iron loading of cultured cardiac myocytes modifies sarcolemmal structure and increases lysosomal fragility. J. Lab. Clin. Med. 1993; 121: 127-134.
6. Yu Z, Persson HL, Eaton JW, Brunk UT. Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Radic. Biol. Med. 2003; 34: 1243-1252.
7. Richardson DR, Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1997; 1331: 1-40.
8. Conrad ME, Umbreit JN, Moore EG. Iron absorption and transport. Am. J. Med. Sci. 1999; 318: 213-229.
9. Moos T, Morgan EH. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann. NY Acad. Sci. 2004; 1012: 14-26.
10. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest. Radiol. 2004; 39: 56-63.
11. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH Jr, Bulte JW. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228: 480-487.
12. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, Frank JA. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 2003; 76: 1123-1130.
13. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003; 229: 838-846.
14. Skotland T, Sontum PC, Oulie I. In vitro stability analyses as a model for metabolism of ferromagnetic particles (ClariscanTM), a contrast agent for magnetic resonance imaging. J. Pharm. Biomed. Anal. 2002; 28: 323-329.
15. Jung CW. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imag. 1995; 13: 675-691.
16. Hendrick RE, Haacke EM. Basic physics of MR contrast agents and maximization of image contrast. J. MRI 1993; 3: 137-148.
17. Nitz WR, Reimer P. Contrast mechanisms in MR imaging. Eur. Radiol. 1999; 9: 1032-1046.
18. Wood ML, Hardy PA. Proton relaxation enhancement. J. MRI 1998; 3: 149-156.
19. Hardy PA, Henkelman RM. On the transverse relaxation rate enhancement induced by diffusion of spins through inhomogenesous fields. Magn. Reson. Med. 1991; 17: 348-356.
20. Josephson L, Lewis J, Jacobs P, Hahn PF, Stark DD. The effects of iron oxides on proton relaxivity. Magn. Reson. Imag. 1988; 6: 647-653.
21. Majumdar S, Zoghbi SS, Gore JC. The influence of pulse sequence on the relaxation effects of superparamagnetic iron oxide contrast agents. Magn. Reson. Med. 1989; 10: 289-301.
22. Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed. Pharmacother. 2001; 55: 333-339.
23. Arosio P, Levi S. Iron and cellular redox status. Free Rad. Biol. Med. 2002; 33: 457-463.
24. Aisen P, Wessling-Resnick M, Leibold EA. Iron metabolism. Curr. Opin. Chem. Biol. 1999; 3: 200-206.
25. Trinder D, Fox C, Vautier G, Olynyk JK. Molecular pathogenesis of iron overload. Gut 2002; 51: 290-295.
26. Crichton RR, Wilmet S, Legssyer R, Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J. Inorg. Biochem. 2002; 91: 9-18.
27. Crinhton RR, Ward RJ. An overview of iron metabolism: molecular and cellular criteria for selection of iron chelators. Curr. Med. Chem. 2003; 10: 997-1004.
28. Garner B, Roberg K, Brunk UT. Endogenous ferritin protects cells with iron-laden lysosomes against oxidative stress. Free Rad. Res. 1998; 29: 103-114.
29. Gutteridge JMC, Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radical and lipid peroxidation in the presence of iron salt: detection of catalytic iron and antioxidant activity in extracellular fluids. Biochem. J. 1982; 206: 605-609.
30. 3+ to plasma membrane of lactating mouse mammary gland. J. Inorg. Biochem. 1990; 40: 323-329.
31. Schmid A, Jakob E, Berg A, Russmann T, Konig D, Irmer M, Keul J. Effect of physical exercise and vitamin C on absorption of ferric sodium citrate. Med. Sci. Sports Exerc. 1996; 28: 1470-1473.
32. 3+ by transferrin. Implications for the interlocking sites hypothesis. J. Biol. Chem. 1975; 250: 2183-2188.
33. Arbab AS, Jordan EK, Wilson LB, Yocum GT, Lewis BK, Frank JA. In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum. Gene Ther. 2004; 15: 351-360.